BridgeMD
New treatment option for Post Operative Pain
Official title Post Operative Infusion Pump Pain Study
ClinicalTrials.gov ID: NCT07349810
What this study is testing
What is Bupivacaine 0.5% Injectable Solution?
Bupivacaine 0.5% Injectable Solution is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for post operative pain.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study will be a pragmatic, prospective cluster randomized trial, where clusters will formed based on sequential 2 week time increments across the study recruitment period.. Patients 18 years or older undergoing ACL reconstruction, open shoulder labrum or rotator cuff surgery, arthroscopic rotator cuff repair, proximal or distal patellar realignment surgery, open knee arthrotomy cases (i.e.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 years or older
- ACL reconstruction
- Open shoulder labrum or rotator cuff surgery
- Arthroscopic rotator cuff repair
- Proximal or distal patellar realignment surgery
You likely can't join if
- Age under 18 years
- Body mass index of greater than 40 kg/m2
- American Society of Anesthesiologist class 4 physical status or greater
- History of drug or alcohol abuse
- Chronic opioid use/pain management doctor
- Allergy to bupivacaine, ropivacaine or pharmacologic analogs
See the full eligibility criteria
- Age 18 years or older
- ACL reconstruction
- Open shoulder labrum or rotator cuff surgery
- Arthroscopic rotator cuff repair
- Proximal or distal patellar realignment surgery
- Open knee arthrotomy cases - Inside out meniscus repair, OCA, MAT
- Age under 18 years
- Body mass index of greater than 40 kg/m2
- American Society of Anesthesiologist class 4 physical status or greater
- History of drug or alcohol abuse
- Chronic opioid use/pain management doctor
- Allergy to bupivacaine, ropivacaine or pharmacologic analogs
- Any coagulation disorders
- Existing nerve injury
- Severe bronchopulmonary disease
- Pregnant patients
The study team makes the final eligibility decision.
Where it's taking place
- Somerset, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Somerset, New Jersey, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.